Metabolic syndrome components and colorectal adenoma in the CLUE II cohort

Cancer Causes and Control

Volumn 21, Issue 1, 2010, Pages 1-10

  Tsilidis, Konstantinos K ^a   Brancati, Frederick L ^a,b,c   Pollak, Michael N ^d   Rifai, Nader ^e   Clipp, Sandra L ^a   Hoffman Bolton, Judith ^a   Helzlsouer, Kathy J ^a,f,g   Platz, Elizabeth A ^a,g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f MERCY MEDICAL CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Colorectal neoplasia; Insulin resistance; Prospective study

Indexed keywords

ACETYLSALICYLIC ACID; C PEPTIDE; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; COLON ADENOMA; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM ADENOMA; SIGMOIDOSCOPY;

ADENOMA; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MARYLAND; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 74149084208     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9428-6     Document Type: Article

References (44)

1. E Giovannucci 2003 Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence J Womens Health (Larchmt) 12 173 182 10.1089/154099903321576574
2. R Villegas A Salim A Flynn IJ Perry 2004 Prudent diet and the risk of insulin resistance Nutr Metab Cardiovasc Dis 14 334 343 10.1016/S0939-4753(04) 80023-1 1:CAS:528:DC%2BD2MXjvF2nurs%3D 15853117 (Pubitemid 40459256)
3. G McKeown-Eyssen 1994 Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 3 687 695 1:STN:280:DyaK2M7oslSktA%3D%3D
4. E Giovannucci 1995 Insulin and colon cancer Cancer Causes Control 6 164 179 10.1007/BF00052777 1:STN:280:DyaK2M3msl2kuw%3D%3D 7749056
5. S Cowey RW Hardy 2006 The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169 1505 1522 10.2353/ajpath.2006.051090 1:CAS:528:DC%2BD28Xht12isr7K 17071576 (Pubitemid 351181984)
6. R Kaaks P Toniolo A Akhmedkhanov A Lukanova C Biessy H Dechaud, et al. 2000 Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women J Natl Cancer Inst 92 1592 1600 10.1093/jnci/92.19.1592 1:CAS:528:DC%2BD3cXnsVKitrw%3D 11018095
7. J Ma E Giovannucci M Pollak A Leavitt Y Tao JM Gaziano, et al. 2004 A prospective study of plasma C-peptide and colorectal cancer risk in men J Natl Cancer Inst 96 546 553 1:CAS:528:DC%2BD2cXjtVShtbw%3D 15069117 (Pubitemid 38559579)
8. T Otani M Iwasaki S Sasazuki M Inoue S Tsugane 2007 Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study Int J Cancer 120 2007 2012 10.1002/ijc.22556 1:CAS:528:DC%2BD2sXjsVCqsbY%3D 17266031 (Pubitemid 46418381)
9. M Jenab E Riboli RJ Cleveland T Norat S Rinaldi A Nieters, et al. 2007 Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition Int J Cancer 121 368 376 10.1002/ijc.22697 1:CAS:528:DC%2BD2sXmslOlt7Y%3D 17372899 (Pubitemid 46917707)
10. EA Platz SE Hankinson N Rifai GA Colditz FE Speizer E Giovannucci 1999 Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States) Cancer Causes Control 10 379 386 10.1023/A:1008953611657 1:STN:280:DyaK1MvlvVWqsg%3D%3D 10530607 (Pubitemid 29454314)
11. SH Saydah EA Platz N Rifai MN Pollak FL Brancati KJ Helzlsouer 2003 Association of markers of insulin and glucose control with subsequent colorectal cancer risk Cancer Epidemiol Biomark Prev 12 412 418 1:CAS:528: DC%2BD3sXjsleitLo%3D
12. KT Khaw N Wareham S Bingham R Luben A Welch N Day 2004 Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study Cancer Epidemiol Biomark Prev 13 915 919
13. EK Wei J Ma MN Pollak N Rifai CS Fuchs SE Hankinson, et al. 2005 A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women Cancer Epidemiol Biomark Prev 14 850 855 10.1158/1055-9965.EPI-04-0661 1:CAS:528:DC%2BD2MXjtFSkur0%3D (Pubitemid 40478547)
14. J Lin PM Ridker A Pradhan IM Lee JE Manson NR Cook, et al. 2005 Hemoglobin A1c concentrations and risk of colorectal cancer in women Cancer Epidemiol Biomark Prev 14 3010 3012 10.1158/1055-9965.EPI-05-0533 1:CAS:528:DC%2BD2MXhtlahs7jK (Pubitemid 43068841)
15. T Stocks A Lukanova M Johansson S Rinaldi R Palmqvist G Hallmans, et al. 2007 Components of the metabolic syndrome and colorectal cancer risk; a prospective study Int J Obes (Lond) 32 304 314 10.1038/sj.ijo.0803713
16. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC, pp 210-229
17. M Gaard S Tretli P Urdal 1997 Blood lipid and lipoprotein levels and the risk of cancer of the colon and rectum. A prospective study of 62,173 Norwegian men and women Scand J Gastroenterol 32 162 168 10.3109/00365529709000187 1:CAS:528:DyaK2sXhsVWmsLY%3D 9051877
18. R Jarvinen P Knekt T Hakulinen H Rissanen M Heliovaara 2001 Dietary fat, cholesterol and colorectal cancer in a prospective study Br J Cancer 85 357 361 10.1054/bjoc.2001.1906 1:CAS:528:DC%2BD3MXmslSgtr0%3D 11487265 (Pubitemid 32747702)
19. AM Nomura GN Stemmermann PH Chyou 1991 Prospective study of serum cholesterol levels and large-bowel cancer J Natl Cancer Inst 83 1403 1407 10.1093/jnci/83.19.1403 1:STN:280:DyaK38%2FhsFejtg%3D%3D 1920483
20. RL Ahmed KH Schmitz KE Anderson WD Rosamond AR Folsom 2006 The metabolic syndrome and risk of incident colorectal cancer Cancer 107 28 36 10.1002/cncr.21950 16721800 (Pubitemid 43941640)
21. K Bowers D Albanes P Limburg P Pietinen PR Taylor J Virtamo, et al. 2006 A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers Am J Epidemiol 164 652 664 10.1093/aje/kwj253 16877536 (Pubitemid 44453494)
22. LA Colangelo SM Gapstur PH Gann AR Dyer K Liu 2002 Colorectal cancer mortality and factors related to the insulin resistance syndrome Cancer Epidemiol Biomark Prev 11 385 391
23. T Sturmer JE Buring IM Lee JM Gaziano RJ Glynn 2006 Metabolic abnormalities and risk for colorectal cancer in the physicians' health study Cancer Epidemiol Biomark Prev 15 2391 2397 10.1158/1055-9965.EPI-06-0391 (Pubitemid 46048295)
24. M Trevisan J Liu P Muti G Misciagna A Menotti F Fucci 2001 Markers of insulin resistance and colorectal cancer mortality Cancer Epidemiol Biomark Prev 10 937 941 1:CAS:528:DC%2BD3MXnt1Gis70%3D
25. CL Bird SA Ingles HD Frankl ER Lee MP Longnecker RW Haile 1996 Serum lipids and adenomas of the left colon and rectum Cancer Epidemiol Biomark Prev 5 607 612 1:STN:280:DyaK28vitFOntw%3D%3D
26. E Giovannucci A Ascherio EB Rimm GA Colditz MJ Stampfer WC Willett 1995 Physical activity, obesity, and risk for colon cancer and adenoma in men Ann Intern Med 122 327 334 1:STN:280:DyaK2M7ltVejug%3D%3D 7847643
27. E Giovannucci GA Colditz MJ Stampfer WC Willett 1996 Physical activity, obesity, and risk of colorectal adenoma in women (United States) Cancer Causes Control 7 253 263 10.1007/BF00051301 1:STN:280:DyaK28zivVKjug%3D%3D 8740738 (Pubitemid 26155463)
28. S Kono K Imanishi K Shinchi F Yanai 1993 Serum lipids and left-sided adenomas of the large bowel: an extended study of self-defense officials in Japan Cancer Causes Control 4 117 121 10.1007/BF00053152 1:STN:280: DyaK3s3ksVeqtw%3D%3D 8481490
29. EA Platz E Giovannucci EB Rimm HR Rockett MJ Stampfer GA Colditz, et al. 1997 Dietary fiber and distal colorectal adenoma in men Cancer Epidemiol Biomark Prev 6 661 670 1:STN:280:DyaK2svktl2jsw%3D%3D
30. EK Wei J Ma MN Pollak N Rifai CS Fuchs SE Hankinson, et al. 2006 C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women Cancer Epidemiol Biomark Prev 15 750 755 10.1158/1055-9965.EPI-05-0820 1:CAS:528: DC%2BD28XjsVWrtLs%3D
31. JH Kim YJ Lim YH Kim IK Sung SG Shim SO Oh, et al. 2007 Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomark Prev 16 1543 1546 10.1158/1055-9965.EPI-07-0199 1:CAS:528:DC%2BD2sXos1equrg%3D (Pubitemid 47294817)
32. T Morita S Tabata M Mineshita T Mizoue MA Moore S Kono 2005 The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study Asian Pac J Cancer Prev 6 485 489 16435997
33. YY Wang SY Lin WA Lai PH Liu WH Sheu 2005 Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population J Gastroenterol Hepatol 20 1410 1415 10.1111/j.1440-1746.2005.03971.x 16105129 (Pubitemid 43960840)
34. KK Tsilidis TP Erlinger N Rifai S Hoffman J Hoffman-Bolton KJ Helzlsouer, et al. 2008 C-reactive protein and colorectal adenoma in the CLUE II cohort Cancer Causes Control 19 559 567 10.1007/s10552-008-9117-x 18214695
35. Masharani U, Karam JH, German MS (2004) Pancreatic hormones and diabetes mellitus. In: Greenspan FS, Gardner DG (eds) Basic and clinical endocrinology. McGraw-Hill, New York, pp 658-746
36. DR Powell A Suwanichkul ML Cubbage LA DePaolis MB Snuggs PD Lee 1991 Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1 J Biol Chem 266 18868 18876 1:CAS:528: DyaK3MXlsFWhs70%3D 1717456
37. H Rochman 1980 Hemoglobin A1c and diabetes mellitus Ann Clin Lab Sci 10 111 115 1:CAS:528:DyaL3cXhslynu7w%3D 6770740
38. PO Kwiterovich Jr S White T Forte PS Bachorik H Smith A Sniderman 1987 Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia Arteriosclerosis 7 211 225 3593067
39. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet 366 1059 1062 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
40. E Giovannucci 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence J Nutr 131 3109S 3120S 1:CAS:528:DC%2BD3MXosVGitb4%3D 11694656
41. R Palmqvist P Stattin S Rinaldi C Biessy R Stenling E Riboli, et al. 2003 Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden Int J Cancer 107 89 93 10.1002/ijc.11362 1:CAS:528:DC%2BD3sXntlKmt78%3D 12925961 (Pubitemid 37100090)
42. SC Larsson N Orsini A Wolk 2005 Diabetes mellitus and risk of colorectal cancer: a meta-analysis J Natl Cancer Inst 97 1679 1687 16288121 (Pubitemid 41672234)
43. AH Eliassen SS Tworoger CS Mantzoros MN Pollak SE Hankinson 2007 Circulating insulin and C-peptide levels and risk of breast cancer among predominately premenopausal women Cancer Epidemiol Biomark Prev 16 161 164 10.1158/1055-9965.EPI-06-0693 1:CAS:528:DC%2BD2sXks1CrsQ%3D%3D (Pubitemid 46174280)
44. IS Ockene CE Matthews N Rifai PM Ridker G Reed E Stanek 2001 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults Clin Chem 47 444 450 1:CAS:528: DC%2BD3MXhvVOgtLw%3D 11238295